Consolidation nivolumab/ipilimumab versus nivolumab following concurrent chemoradiation in patients with unresectable stage III NSCLC: A planned interim safety analysis from the BTCRC LUN 16-081 trial.Melissa Yan, Nasser H. Hanna, Salma K. Jabbour et al.|Journal of Clinical Oncology|2020Cited by 12
Brief Report: The Immune Profiles of the Molecular Subtypes of EGFR-Mutant Lung Adenocarcinomas in a Large Real-World CohortJ. Nicholas Bodor, Joseph Treat, Joanne Xiu et al.|Clinical Lung Cancer|2024Cited by 1